Drugs & Targets FDA accepts BLA for mosunetuzumab in relapsed or refractory follicular lymphoma July 08, 2022Vol.48 No.27
Drugs & Targets AstraZeneca to acquire TeneoTwo and its clinical-stage T-cell engager, TNB-486 July 08, 2022Vol.48 No.27
Capitol Hill ARPA-H placed outside NIH in authorization bill approved in a 336-85 House vote June 24, 2022Vol.48 No.25By Alice Tracey
NCI strategy for evaluating MCED assays may bypass cancer clinical trials groups June 24, 2022Vol.48 No.25By Paul Goldberg and Alice Tracey
In Brief Alex A. Adjei named chair of Cleveland Clinic Taussig Cancer Institute June 24, 2022Vol.48 No.25
